Ascendis Pharma A (ASND) Tax Rate (2014 - 2026)

Ascendis Pharma A's (ASND) quarterly Tax Rate came in at 1406.31% in Q1 2026, up 140517.0% year-on-year from N/an in Q1 2025, and up 5376.94% quarter-over-quarter from 25.68% in Q4 2025.

Ascendis Pharma A (ASND) Tax Rate (2014 - 2026) Analysis & Trends

Ascendis Pharma A has disclosed Tax Rate across 13 years of filings, most recently posting 1406.31% for Q1 2026.

  • Tax Rate for Q1 2026 came in at 1406.31%, up 140517.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 417.0% (up 41600.0% YoY), and the FY2025 annual result was 18.67%, up 1996.0% from the prior year.
  • Tax Rate came in at 1406.31% for Q1 2026 at Ascendis Pharma A, up from 25.68% in the prior quarter.
  • In the past five years, Tax Rate ranged from a high of 1406.31% in Q1 2026 to a low of 1.95% in Q1 2024.
  • The 5-year median for Tax Rate is 1.04% (2024), against an average of 85.96%.
  • Across the five-year window, Tax Rate tumbled 424 bps in 2024 and jumped 140517 bps in 2026, its largest moves.
  • Ascendis Pharma A's Tax Rate stood at 2.65% in 2022, then jumped by 170 bps to 7.14% in 2023, then tumbled by 59 bps to 2.9% in 2024, then soared by 785 bps to 25.68% in 2025, then jumped by 5377 bps to 1406.31% in 2026.
  • The last three Tax Rate figures came in at 1406.31% (Q1 2026), 25.68% (Q4 2025), and 6.3% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Tax Rate (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -57.14
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -6.79
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 5.61
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 17.68
9 Abivax 91.96 Bn 91.96 Bn - -
10 Ascendis Pharma A 2.75 Bn 2.08 Bn 268.20 Mn 1,406.31

Historic Data

Download Data
DateValue
Mar 31, 2026 1,406.31%
Mar 31, 2026 1,406.31%
Dec 31, 2025 25.68%
Dec 31, 2025 25.68%
Sep 30, 2025 6.30%
Sep 30, 2025 6.30%
Jun 30, 2025 10.99%
Jun 30, 2025 10.99%
Mar 31, 2025 1.13%
Mar 31, 2025 1.13%
Dec 31, 2024 2.90%
Dec 31, 2024 2.90%
Sep 30, 2024 1.04%
Sep 30, 2024 1.04%
Jun 30, 2024 0.21%
Jun 30, 2024 0.21%
Mar 31, 2024 -1.95%
Mar 31, 2024 -1.95%
Dec 31, 2023 7.14%
Dec 31, 2023 7.14%